Press "Enter" to skip to content

Posts tagged as “FDA”

Most recent FDA COVID-19 updates

The US Food and Drug Administration (FDA) has maintained its standing as a useful resource of recommendation and motion for pharmaceutical, scientific trial and life…

This week’s FDA COVID-19 updates

To date, there have been 15.3m confirmed COVID-19 instances world wide, with about 4m within the US alone. In response to the pandemic, the US…

Latest FDA advice and actions on COVID-19

The US Food and Drug Administration (FDA) has remained lively and on prime of the COVID-19 pandemic. Over the course of the previous seven days,…

FDA approves ViiV Healthcare’s HIV treatment

ViiV Healthcare, an HIV specialist firm majority-owned by GSK, has introduced the US Food and Drug Administration (FDA) has accredited Rubobia (forstemsavir) 600-mg prolonged launch…

This week’s FDA COVID-19 news

The US Food and Drug Administration (FDA) continues to offer recommendation and assets for professionals within the life-science business, starting from how one can safely…

This week’s FDA COVID-19 updates

While the COVID-19 continues to influence professionals in pharmaceutical improvement, scientific trials and different life-sciences fields, the US Food and Drug Administration (FDA) continues to…

FDA advises API makers on COVID-19 safe practices

On June 19, the US Food and Drug Administration (FDA) launched a steering doc for the pharmaceutical trade, “Good Manufacturing Practice Considerations for Responding to…

FDA COVID-19 updates for the week

The COVID-19 pandemic has brought about dramatic interruptions throughout all industries, however medical trial and drug improvement professionals are eager on persevering with their work.…